Analyst Ratings for BeOne Medicines (ONC)
ONC Rating Summary
ONC Price Target Summary
- Highest: $454.00 (TD Cowen)
- Lowest: $340.00 (Wolfe Research)
- Average: $413.92
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$413.92 (+15.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$413.92 (+15.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Jefferies | Faisal Khurshid | Upgrade | Buy (Hold) |
380.00 (333.00) |
302.83 (302.83) |
0% | Details |
| 5/20/2026 | JPMorgan » Updated 7/23/2026 |
Jessica Fye | New Coverage | Overweight (N/A) |
425.00 (415.00) |
293.09 (358.66) |
22.37% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
